Grifois (GRFS)

• Market cap: $5.6B
• 1 day: -0.12%
• 5 days: 1.35%
• 1 month: -0.24%
• 3 months: -12.45%
• 6 months: -12.73%
• Year to date: -10.93%
• 1 year: 17.24%
• 5 years: -52.23%
• 10 years: -48.24%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Employees: 25,247